30-Sep-2026
No headlines found.
No press releases found.
No news found.
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Xbiotech trades on the NASDAQ stock market under the symbol XBIT.
As of September 30, 2026, XBIT stock price climbed to $2.19 with 58,683 million shares trading.
XBIT has a beta of 0.51, meaning it tends to be less sensitive to market movements. XBIT has a correlation of 0.04 to the broad based SPY ETF.
XBIT has a market cap of $66.76 million. This is considered a Micro Cap stock.
In the last 3 years, XBIT traded as high as $9.96 and as low as $2.09.
The top ETF exchange traded funds that XBIT belongs to (by Net Assets): VXF, IWC, BSVO, AVSC.
XBIT has underperformed the market in the last year with a return of -17.7%, while the SPY ETF gained +15.6%. In the last 3 month period, XBIT fell short of the market, returning -4.8%, while SPY returned +2.4%. However, in the most recent 2 weeks XBIT has outperformed the stock market by returning +1.9%, while SPY returned +1.4%.
XBIT support price is $2.14 and resistance is $2.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XBIT shares will trade within this expected range on the day.
